Molecular impact of mutations in RNA splicing factors in cancer
Molecular Cell · 2024-10 · 84 (19) · 3667-3680
DOI: 10.1016/j.molcel.2024.07.019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Cell, 2024-10. Verfasst von Qian Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Hauptthemen laut MEDLINE: Mutation, Neoplasms, RNA Splicing Factors. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NHLBI NIH HHS, Edward P Evans Foundation.
Abstract (Originalsprache)
Somatic mutations in genes encoding components of the RNA splicing machinery occur frequently in multiple forms of cancer. The most frequently mutated RNA splicing factors in cancer impact intronic branch site and 3' splice site recognition. These include mutations in the core RNA splicing factor SF3B1 as well as mutations in the U2AF1/2 heterodimeric complex, which recruits the SF3b complex to the 3' splice site. Additionally, mutations in splicing regulatory proteins SRSF2 and RBM10 are frequent in cancer, and there has been a recent suggestion that variant forms of small nuclear RNAs (snRNAs) may contribute to splicing dysregulation in cancer. Here, we describe molecular mechanisms by which mutations in these factors alter splice site recognition and how studies of this process have yielded new insights into cancer pathogenesis and the molecular regulation of splicing. We also discuss data linking mutant RNA splicing factors to RNA metabolism beyond splicing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: abdelwao@mskcc.org.
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- Edward P Evans Foundation
- NHLBI
- National Cancer Institute
- National Institutes of Health
- Leukemia and Lymphoma Society
- Foundation Medicine
Zitieren
APA
Zhang, Q., Ai, Y., & Abdel-Wahab, O. (2024). Molecular impact of mutations in RNA splicing factors in cancer. Molecular Cell, 84(19), 3667-3680. https://doi.org/10.1016/j.molcel.2024.07.019
Vancouver
Zhang Q, Ai Y, Abdel-Wahab O. Molecular impact of mutations in RNA splicing factors in cancer. Molecular Cell. 2024;84(19):3667-3680. doi:10.1016/j.molcel.2024.07.019
BibTeX
@article{Zhang2024,
author = {Zhang, Qian and Ai, Yuxi and Abdel-Wahab, Omar},
title = {Molecular impact of mutations in RNA splicing factors in cancer},
journal = {Molecular Cell},
year = {2024},
volume = {84},
number = {19},
pages = {3667--3680},
doi = {10.1016/j.molcel.2024.07.019}
}
EUVIMED